R. Furbass et al., TISSUE-SPECIFIC EXPRESSION OF THE BOVINE AROMATASE-ENCODING GENE USESMULTIPLE TRANSCRIPTIONAL START SITES AND ALTERNATIVE FIRST EXONS, Endocrinology, 138(7), 1997, pp. 2813-2819
Here we report on the genomic structure of the bovine aromatase cytoch
rome P450-encoding gene (Cyp19) and its tissue-specific transcript var
iants. The gene comprises at least 14 exons (1.1, 1.2a, 1.2b, 1.3, 1.4
, and 2-10) spanning more than 56 kilobases of genomic DNA. The coding
area is confined to exons 2-10. Transcriptional start sites of Cyp19
were examined in granulosa cells, placenta, testis, adrenal gland, and
brain, employing 5'-RACE (rapid amplification of complementary DNA en
ds) and primer extension. The analysis of 5'-RACE clones revealed six
Cyp19 transcript variants that were different within their 5'-untransl
ated regions (5'-UTR). Yet, the coding region was identical in all clo
nes. Although two of these 5'-UTR (the first 152 nucleotides of exon 2
and exon 1.4) are conserved among different species, four others (exo
ns 1.1, 1.2a, 1.2b, and 1.3) did not show sequence homology to any oth
er species. Transcription from exons 1.1 and 2 starts at several adjac
ent sites. In granulosa cells and placenta, but not in brain, a fracti
on of transcripts starting with exon 1.2a contains an additional untra
nslated exon, 1.2b, due to alternative splicing. Transcript Variants c
omprising exon 1.1, 1.2a, 1.2b, or 1.3 were mainly found in the placen
ta, those with the 5'-UTR of exon 2 were predominant in granulosa cell
s, and transcripts with exon 1.4 prevailed in the brain. Estimates of
Cyp19 transcript concentrations in six different tissues revealed high
levels in granulosa cells and placenta, intermediate levels in testis
and brain, and low levels in adrenal gland and liver. Our experiments
demonstrate that six transcript variants of the bovine Cyp19 gene, in
cluding 9-11 exons, are expressed with tissue-specific preferences. Th
ese transcripts are presumably generated using five different promoter
regions and tissue-specific alternative splicing.